Leinco Technologies

Recombinant Human MIP-1α (CCL3L1)

Product Code:
 
LEI-L145
Product Group:
 
Recombinant Proteins
Host Type:
 
Human
Regulatory Status:
 
RUO
Shipping:
 
Ambient
Storage:
 
This lyophilized protein is stable for six to twelve months when stored desiccated at -20°C to -70°C. After aseptic reconstitution this protein may be stored at 2°C to 8°C for one month or at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. See Product Insert for exact lot specific storage instructions.
 

No additional charges, what you see is what you pay! *

CodeSizePrice
LEI-L145-25ug25 ug£443.00
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: US.
Typical lead time: 14-21 working days.
Contact us for more accurate information.
  • Further Information
  • References
  • Show All

Further Information

Format:
This recombinant protein was lyophilized from a 0.2 um filtered solution in 35% acetonitrile (CH3CN) and 0.1% trifluoroacetic acid (TFA).
Formulation:
This recombinant protein was lyophilized from a 0.2 um filtered solution in 35% acetonitrile (CH3CN) and 0.1% trifluoroacetic acid (TFA).
Long Description:
Chemokine (C-C motif) ligand 3-like 1, also known as CCL3L1 is a member of the CC chemokine family that exhibits a variety of pro-inflammatory activities including chemotaxis, and functional and proliferative activation of leukocytes, lymphocytes and macrophages.1 CCL3L1 a potent human immunodeficiency virus-1 (HIV-1)-suppressive chemokine and ligand for the HIV co-receptor CCR5.2 CCL3L1-CCR5 genotype may provide critical guidance for optimizing the design and evaluation of HIV-1 vaccine trials and prevention programs.3
NCBI Gene:
6349
Purity:
>97% by SDS-PAGE and analyzed by silver stain.
Target:
MIP-1 alpha

References

1. Emi, M. et al. (2004) J Neurooncol. 70: 301 2. Ahuja, SK. et al. (2005) Science 307: 1434 3. Ahuja, SK. et al. (2008) PLoS One 3: e3671